Dr. Dirk Nagorsen brings more than 25 years of experience in hematology and oncology across academia, clinical practice, and industry leadership. He has held senior roles at leading biopharmaceutical companies including Micromet, Amgen, and Affini-T Therapeutics. During his career, headvanced programs from Research stage to early clinical development through pivotal trials and to regulatory approvals. Trained in internal medicine, hematology, and oncology at Charité University Medicine Berlin, the NIH Clinical Center, and Free University Berlin, Dr. Nagorsen also holds a PhD equivalent (habilitation) in experimental medicine and tumor immunology. At Cartography, he is leading clinical strategy and development to advance the company’s pipeline of therapeutics in high unmet need cancers.
Dirk Nagorsen, M.D.
